Add BrightSurf on Google Email

Compuscript Ltd


Aging exacerbates tenofovir-induced mitochondrial toxicity

Researchers used a 3D silk matrix model to study human primary kidney stem cells and found that aging increases susceptibility to tenofovir-induced mitochondrial toxicity, oxidative stress, senescence, and apoptosis. Tenofovir was more toxic to older cells, causing mitochondrial damage and functional injury.

SourceCompuscript Ltd·JournalGenes & Diseases·DateOct 13, 2026

circLPAR3 drives chemotherapy resistance in prostate cancer

Researchers identified circLPAR3 as a key mediator of docetaxel resistance in prostate cancer, promoting tumor growth under chemotherapy by suppressing ferroptosis. The study highlights circLPAR3 as a promising biomarker for treatment response and suggests targeting its regulatory network could help overcome chemotherapy resistance.

SourceCompuscript Ltd·JournalGenes & Diseases·DateSep 29, 2026

Obesity and cardiovascular diseases

This review synthesizes clinical and basic research progress on obesity and CVDs, exploring epidemiology, pathophysiology, and management strategies. The authors highlight the effects of obesity on various CVDs, emphasizing the need for effective prevention and treatment strategies.

SourceCompuscript Ltd·JournalCardiovascular Innovations and Applications·DateAug 27, 2026

Development and validation of DSTOX: an integrated QSAR platform adhering to ICH M7 guidelines for mutagenicity assessment of drug impurities

The DSTOX platform uses a multi-strategy fusion approach to integrate statistical rule-based models, expert knowledge rule-based models, and analogue search for mutagenicity assessment. The platform achieved an accuracy of 92.0% in internal validation and 84.0% in external validation, comparable to mainstream prediction tools.

SourceCompuscript Ltd·JournalActa Materia Medica·DateAug 27, 2026